The clinical implication of that -arrestin-sparing profile is still under investigation, but NIH-funded research published in Nature in May 2026 found that small-molecule GLP-1 drugs access reward circuits deep within the brain circuits involved in hedonic, pleasure-driven feeding through pathways that the larger peptide molecules do not reach, suggesting the two drug classes may suppress appetite through partially distinct neural mechanisms
These symptoms are often dose-dependent and more common during the titration phase. The serious side effects are similar, too
They also consider testicular or pituitary sources of hormone disruption in the right context
Key risk factors include age (over 50), vascular conditions like hypertension and diabetes, lifestyle factors such as smoking and obesity, untreated obstructive sleep apnea, and certain medications
These models exclude taxes, any shipping charge, and the separate official Zepbound page's $499 high-dose price